Haleon plc (HLN) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.071x

Based on the latest financial reports, Haleon plc (HLN) has a cash flow conversion efficiency ratio of 0.071x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($1.13 Billion) by net assets ($16.00 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Haleon plc - Cash Flow Conversion Efficiency Trend (2019–2024)

This chart illustrates how Haleon plc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Haleon plc debt and liabilities for a breakdown of total debt and financial obligations.

Haleon plc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Haleon plc ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
NTPC Limited
NSE:NTPC
0.253x
Ameriprise Financial Inc
NYSE:AMP
-0.422x
Victory Giant Technology Huizhou Co Ltd
SHE:300476
0.134x
CoreWeave, Inc. Class A Common Stock
NASDAQ:CRWV
0.467x
Entergy Corporation
NYSE:ETR
0.126x
Sungrow Power Supply Co Ltd
SHE:300274
0.137x
AngloGold Ashanti Ltd
JSE:ANG
0.153x
Adani Ports and Special Economic Zone Limited
NSE:ADANIPORTS
0.136x

Annual Cash Flow Conversion Efficiency for Haleon plc (2019–2024)

The table below shows the annual cash flow conversion efficiency of Haleon plc from 2019 to 2024. For the full company profile with market capitalisation and key ratios, see Haleon plc (HLN) total market value.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 $16.22 Billion $2.30 Billion 0.142x +12.98%
2023-12-31 $16.73 Billion $2.10 Billion 0.126x +0.14%
2022-12-31 $16.46 Billion $2.06 Billion 0.125x +144.80%
2021-12-31 $26.48 Billion $1.36 Billion 0.051x -4.56%
2020-12-31 $26.22 Billion $1.41 Billion 0.054x +87.12%
2019-12-31 $27.41 Billion $786.00 Million 0.029x --

About Haleon plc

NYSE:HLN USA Drug Manufacturers - Specialty & Generic
Market Cap
$41.77 Billion
Market Cap Rank
#636 Global
#302 in USA
Share Price
$9.38
Change (1 day)
+1.52%
52-Week Range
$8.72 - $11.41
All Time High
$11.41
About

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Aquafresh, and Biotene… Read more